Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder

Cognitive Brain Research

Volumn 16, Issue 3, 2003, Pages 425-433

  Konrad, Kerstin ^a   Gauggel, Siegfried ^b   Schurek, Josef ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b CHEMNITZ UNIVERSITY OF TECHNOLOGY   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Attention deficit hyperactivity disorder; Eyeblink rate; Traumatic brain injury; Urinary catecholamines

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORMETADRENALIN;

ADOLESCENT; APTITUDE TEST; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN INJURY; CATECHOLAMINE URINE LEVEL; COGNITION; CONTROLLED STUDY; DISEASE MARKER; DOPAMINERGIC ACTIVITY; EXCRETION; EYELID REFLEX; HUMAN; MAJOR CLINICAL STUDY; NERVE CELL NETWORK; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS;

EID: 0037403859     PISSN: 09266410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-6410(03)00057-0     Document Type: Article

References (35)

1. Anderson G.M., Dover M.A., Benson P.Y., Holahan J.M., Shaywitz S.E., Marchione K.E., Hall L.M., Fletcher J.M., Shaywitz B.A. Adrenomedullary function during cognitive testing in Attention-Deficit/Hyperactivity Disorder. J. Am. Acad. Child Adolesc. Psychiatry. 39:2000;635-643.
2. Arcia E., Gualtieri C.T. Neurobehavioural performance of adults with closed-head injury, adults with attention deficit, and controls. Brain Inj. 8:1994;395-404.
3. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn. Sci. 2:1998;436-446.
4. Arnsten A.F., Steere J.C., Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry. 53:1996;448-455.
5. Caplan R., Guthrie D., Komo S. Blink rate in children with attention-deficit-hyperactivity disorder. Biol. Psychiatry. 39:1996;1032-1038.
6. Cyr M., Brown C.S. Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. Drugs. 56:1998;215-223.
7. Daugherty T.K., Quay H.C., Ramos L. Response perseveration, inhibitory control, and central dopaminergic activity in childhood behavior disorders. J. Gen. Psychol. 154:1993;177-188.
8. Döpfner M., Lehmkuhl G. Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV. 1998;Huber Verlag, Bern.
9. 123I-IBZM. Eur. J. Nucl. Med. 27:2000;1410-1414.
10. Elia J., Borcherding B.G., Potter W.Z., Mefford I.N., Rapoport J.L., Keysor C.S. Stimulant drug treatment of hyperactivity: biochemical correlates. Clin. Pharmacol. Ther. 48:1990;57-66.
11. Elwood S.W., Ferguson H.B., Thakar J. Catecholamine response of children in a naturally occurring stressor situation. J. Hum. Stress. 12:1986;154-161.
12. Glowinski J., Besson M.J., Cheramy A. Role of the thalamus in the bilateral regulation of dopaminergic and GABAergic neurons in the basal ganglia. Ciba Found. Symp. 107:1984;150-163.
13. Halperin J.M., Newcorn J.H., Koda V.H., Pick L., McKay K.E., Knott P. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J. Am. Acad. Child Adolesc. Psychiatry. 36:1997;1688-1697.
14. Hanna G.L., Ornitz E.M., Hariharan M. Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys. Biol. Psychiatry. 40:1996;553-555.
15. Hornyak J.E., Nelson V.S., Hurvitz E.A. The use of methylphenidate in pediatric traumatic brain injury. Pediatr. Rehabil. 1:1997;15-17.
16. Karson C.N. Spontaneous eye-blink rates and dopaminergic systems. Brain. 106:1983;643-653.
17. Khan A.U., Dekirmenjian H. Urinary excretion of catecholamine metabolites in hyperkinetic children. Am. J. Psychiatry. 138:1981;108-112.
18. Konrad K., Gauggel S., Manz A., Schoell M. Inhibitory control in children with traumatic brain injury (TBI) and children with attention-deficit/hyperactivity disorder (ADHD). Brain Inj. 14:2000;859-875.
19. Konrad K., Gauggel S., Manz A., Schoell M. Lack of inhibition: A motivational deficit in children with attention-deficit/hyperactivity disorder (ADHD) and children with traumatic brain injury (TBI). Child. Neuropsychol. 6:2000;286-296.
20. Levin H.S., Kraus M.F. The frontal lobes and traumatic brain injury. J. Neuropsychiatry Clin. Neurosci. 6:1994;443-454.
21. Maas J.W., Leckman J.F. Relationship between central nervous system noradrenergic function and plasma and urinary MHPG and other norepinephrine metabolites. Maas J.W. MHPG: Basic Mechanisms and Psychopathology. 1983;33-44 Academic Press, London.
22. Pliszka S.R., Maas J.W., Javors M.A., Rogeness G.A., Baker J. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J. Am. Acad. Child Adolesc. Psychiatry. 33:1994;1165-1173.
23. Pliszka S.R., McCracken J.T., Maas J.W. Catecholamines in Attention-Deficit Hyperactivity Disorder: Current perspectives. J. Am. Acad. Child Adolesc. Psychiatry. 35:1996;264-271.
24. Pycock C.J., Kerwin R.W., Carter C.J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 286:1980;74-77.
25. Randolph C., Miller M.H., Towner E., Pollack I.W. Autonomic responsivity following CHI. Brain Inj. 12:1992;383-385.
26. Roozendaal B., Carmi O., McGaugh J.L. Adrenocortical suppression block the memory-enhancing effects of amphetamine and epinephrine. Proc. Natl. Acad. Sci. USA. 93:1996;1429-1433.
27. R. Schachar, R. Wachsmuth, Parent Interview for Child Symptoms - Revised DSM-IV. Unpublished manuscript. Toronto, 1989.
28. Solanto M.V. Clinical psychopharmacology of AD/HD: Implications for animal models. Neurosci. Biobehav. Rev. 24:2000;27-30.
29. Swanson J.M., Sunahara G.A., Kennedy J.L., et al. Association of the dopamine receptor D4 (DRD4) gene with a referred phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry. 3:1998;38-41.
30. Teasdale G.M. Head injury. J. Neurol. Neurosurg. Psychiatry. 58:(5):1995;526-539.
31. Tuchman M., Morris C.L., Ramnaraine M.L., Bowers L.D., Krivit W. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-h urine collections. J. Pediatr. 75:1985;324-328.
32. Unnewehr S., Schneider S., Margraf J. Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter. 1995;Springer, Berlin.
33. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. USA. 95:1998;14494-14499.
34. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex. 8:1998;321-345.
35. Zametkin A.J., Stevens J.R., Pittman R. Ontogeny of spontaneous blinking and of habituation of the blink reflex. Ann. Neurol. 5:1979;453-457.